Mar 13, 2024 / 12:00PM GMT
Emily Field - Barclays Bank PLC, Research Division - Head of European Pharmaceuticals Equity Research
Okay. Good morning, everybody. Thanks for joining Day 2 of Barclays Global Healthcare Conference here in Miami. My name is Emily Field. I lead the European equity research team covering European pharmaceuticals out of London. And we're pleased to be joined today by the leaders of Sanofi's immunology team, Shaju Backer, who is the Global Head of the Immunology franchise; and Naimish Patel, who Heads Development for Immunology and Inflammation.
So as we were just getting started here, we thought maybe a good place to start was big therapeutic conference over the weekend, AAD. So I don't know if maybe that would be a good place to start because I know you guys presented a lot of data there. And then we can get into Q&A.
Shaju Backer - Sanofi - Global Head of Immunology Franchise
Sure. Naimish, would you like to kick off with the amlitelimab data we presented at AAD?
Naimish Patel - Sanofi - Head of Global Development,
Sanofi SA at Barclays Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot